Phantom Neuro has secured approval to initiate its first-in-human trial of the Phantom X system, a minimally invasive muscle-machine interface, in Australia, for prosthesis control.

This development marks an essential phase towards commercialisation and clinical trials in the US.

The early feasibility study (EFS), named CYBORG, aims to assess the efficacy, safety and usability of the system designed to allow individuals with limb loss to operate prosthetic hands and robotic devices through natural movements.